Biotechnology
The Biotechnology industry has a total of 594 stocks, with a combined market cap of $1.17 trillion and total revenue of $110.17 billion.
Market Cap
1.17T
Revenue
110.17B
Profits
-40.04B
PE Ratio
n/a
Profit Margin
-36.34%
Dividend Yield
0.04%
594 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 110.67B | -0.59% | 777,646 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.61B | 2.60% | 928,723 | 14.34B |
| 3 | ARGX | argenx SE | 49.93B | -0.66% | 230,402 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.62B | 1.03% | 588,285 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 33.25B | -4.03% | 316,350 | 5.34B |
| 6 | INSM | Insmed Incorporated | 31.05B | -0.45% | 1,152,463 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 29.43B | -0.16% | 2,081,213 | 2.38B |
| 8 | RVMD | Revolution Medicines, Inc. | 28.28B | -4.96% | 4,275,183 | - |
| 9 | BNTX | BioNTech SE | 26.69B | -2.80% | 716,547 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 20.96B | -4.95% | 4,062,675 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 20.14B | -3.46% | 7,595,179 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.00B | -1.31% | 905,082 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 17.28B | -9.40% | 4,971,431 | - |
| 14 | GMAB | Genmab A/S | 16.77B | -2.56% | 1,041,589 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 13.90B | -2.62% | 831,995 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 13.89B | -3.72% | 2,396,802 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.31B | -1.21% | 1,074,646 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.24B | -0.99% | 1,377,409 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.90B | -1.97% | 330,190 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.70B | -1.71% | 2,418,074 | 2.32B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.42B | 0.65% | 2,593,548 | 1.09B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.38B | -0.31% | 1,495,438 | 3.22B |
| 23 | AXSM | Axsome Therapeutics, Inc. | 9.35B | -1.98% | 418,910 | 638.50M |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 9.18B | -2.28% | 324,623 | 7.46M |
| 25 | ABVX | ABIVAX Société Anonyme | 9.09B | -2.58% | 570,625 | 5.37M |
| 26 | PCVX | Vaxcyte, Inc. | 8.75B | -0.07% | 929,730 | - |
| 27 | NUVL | Nuvalent, Inc. | 8.49B | -0.76% | 1,030,311 | - |
| 28 | IBRX | ImmunityBio, Inc. | 8.46B | 1.49% | 9,775,089 | 113.29M |
| 29 | TECH | Bio-Techne Corporation | 8.17B | -10.89% | 3,266,799 | 1.22B |
| 30 | CYTK | Cytokinetics, Incorporated | 8.14B | -1.16% | 1,662,179 | 88.04M |
| 31 | KRYS | Krystal Biotech, Inc. | 7.89B | -2.86% | 160,343 | 389.13M |
| 32 | HALO | Halozyme Therapeutics, Inc. | 7.89B | -2.65% | 2,376,648 | 1.40B |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.12B | -1.80% | 411,182 | 39.21M |
| 34 | ERAS | Erasca, Inc. | 6.98B | 3.79% | 9,454,316 | - |
| 35 | ACLX | Arcellx, Inc. | 6.75B | 0.04% | 1,160,639 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.55B | -2.78% | 651,593 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.52B | -2.64% | 400,390 | - |
| 38 | BLTE | Belite Bio, Inc | 6.47B | -1.77% | 66,100 | - |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.02% | 2,587,554 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.10B | -0.10% | 1,716,217 | 15.00M |
| 41 | SYRE | Spyre Therapeutics, Inc. | 5.97B | -5.15% | 693,335 | - |
| 42 | CGON | CG Oncology, Inc. | 5.90B | 0.01% | 1,121,949 | 4.04M |
| 43 | IMVT | Immunovant, Inc. | 5.88B | -1.97% | 1,333,119 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 5.82B | -0.69% | 1,123,322 | - |
| 45 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.82B | 0.04% | 510,956 | 189.76M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.68B | -3.19% | 657,409 | 1.73B |
| 47 | CAI | Caris Life Sciences, Inc. | 5.59B | -3.46% | 1,540,803 | 812.03M |
| 48 | MIRM | Mirum Pharmaceuticals, Inc. | 5.55B | -2.50% | 317,587 | 521.31M |
| 49 | CELC | Celcuity Inc. | 5.49B | -7.24% | 792,076 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.45B | 0.32% | 1,056,131 | - |
| 51 | TGTX | TG Therapeutics, Inc. | 5.45B | -3.63% | 1,863,475 | 616.29M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.31B | -2.20% | 1,521,115 | 3.51M |
| 53 | XENE | Xenon Pharmaceuticals Inc. | 5.29B | -2.19% | 613,441 | 7.50M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | 0.12% | 2,769,737 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.89B | -1.61% | 356,609 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.84B | -3.20% | 881,456 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.56B | 0.71% | 172,379 | 268.09M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 2,050,721 | 634.21M |
| 59 | LEGN | Legend Biotech Corporation | 4.44B | -7.48% | 2,478,120 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.03B | -1.51% | 658,355 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.80B | -4.23% | 2,521,687 | - |
| 62 | TVTX | Travere Therapeutics, Inc. | 3.77B | 1.82% | 1,816,509 | 490.73M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -0.58% | 1,209,553 | 1.07B |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.73B | -3.97% | 2,895,933 | 62.38M |
| 65 | TLX | Telix Pharmaceuticals Limited | 3.62B | -1.36% | 133,107 | 803.79M |
| 66 | NAMS | NewAmsterdam Pharma Company N.V. | 3.62B | -1.50% | 522,366 | 22.50M |
| 67 | ORKA | Oruka Therapeutics, Inc. | 3.40B | -2.78% | 1,681,461 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.38B | 6.71% | 2,968,446 | 588.99M |
| 69 | EWTX | Edgewise Therapeutics, Inc. | 3.35B | -2.92% | 877,764 | - |
| 70 | GPCR | Structure Therapeutics Inc. | 3.33B | 1.12% | 795,929 | - |
| 71 | ALMS | Alumis Inc. | 3.31B | 0.39% | 1,777,231 | 24.05M |
| 72 | RCUS | Arcus Biosciences, Inc. | 3.15B | -5.60% | 1,526,656 | 247.00M |
| 73 | DYN | Dyne Therapeutics, Inc. | 3.12B | -3.91% | 1,791,995 | - |
| 74 | KLRA | Kailera Therapeutics, Inc. | 3.10B | 3.21% | 3,995,827 | - |
| 75 | DNLI | Denali Therapeutics Inc. | 3.08B | -3.95% | 1,221,096 | - |
| 76 | NKTR | Nektar Therapeutics | 3.03B | -2.08% | 2,161,482 | 55.23M |
| 77 | BEAM | Beam Therapeutics Inc. | 3.02B | -4.83% | 2,694,563 | 139.74M |
| 78 | RLAY | Relay Therapeutics, Inc. | 2.86B | -8.60% | 2,972,587 | 15.36M |
| 79 | ARQT | Arcutis Biotherapeutics, Inc. | 2.84B | -3.75% | 1,061,021 | 376.07M |
| 80 | KOD | Kodiak Sciences Inc. | 2.79B | 0.04% | 635,832 | - |
| 81 | VERA | Vera Therapeutics, Inc. | 2.75B | -4.67% | 864,505 | - |
| 82 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.15% | 1,427,114 | 190.41M |
| 83 | IDYA | IDEAYA Biosciences, Inc. | 2.70B | -3.06% | 1,311,327 | 218.71M |
| 84 | CLDX | Celldex Therapeutics, Inc. | 2.63B | -1.93% | 728,833 | 1.55M |
| 85 | ELVN | Enliven Therapeutics, Inc. | 2.62B | -1.24% | 473,161 | - |
| 86 | IRON | Disc Medicine, Inc. | 2.61B | -1.99% | 294,194 | - |
| 87 | IMNM | Immunome, Inc. | 2.60B | -3.32% | 559,407 | 6.94M |
| 88 | TARS | Tarsus Pharmaceuticals, Inc. | 2.59B | -3.95% | 816,127 | 451.36M |
| 89 | MANE | Veradermics, Incorporated | 2.59B | -1.51% | 236,232 | - |
| 90 | ADMA | ADMA Biologics, Inc. | 2.57B | 1.19% | 6,216,887 | 510.17M |
| 91 | ZLAB | Zai Lab Limited | 2.46B | -4.33% | 745,103 | 460.16M |
| 92 | RARE | Ultragenyx Pharmaceutical Inc. | 2.38B | -1.34% | 1,464,510 | 673.00M |
| 93 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | -1.52% | 762,496 | - |
| 94 | DFTX | Definium Therapeutics, Inc. | 2.32B | 0.78% | 1,965,243 | - |
| 95 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.19% | 2,988,827 | 158.18M |
| 96 | TYRA | Tyra Biosciences, Inc. | 2.18B | -1.77% | 729,718 | - |
| 97 | AAPG | Ascentage Pharma Group International | 2.15B | -11.10% | 9,417 | 82.08M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.15B | -1.71% | 1,253,880 | 283.06M |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 2.14B | -1.07% | 4,956,145 | 2.20B |
| 100 | ADPT | Adaptive Biotechnologies Corporation | 2.13B | -2.68% | 1,006,073 | 276.98M |
| 101 | OCUL | Ocular Therapeutix, Inc. | 2.09B | -0.72% | 2,519,925 | 51.95M |
| 102 | STOK | Stoke Therapeutics, Inc. | 2.07B | -2.70% | 363,649 | 184.42M |
| 103 | MESO | Mesoblast Limited | 2.03B | -1.52% | 292,053 | 65.38M |
| 104 | ZYME | Zymeworks Inc. | 2.02B | -3.86% | 559,818 | 105.97M |
| 105 | TRVI | Trevi Therapeutics, Inc. | 1.99B | -4.12% | 1,789,985 | - |
| 106 | CAPR | Capricor Therapeutics, Inc. | 1.96B | -3.26% | 845,168 | 11.13M |
| 107 | GLPG | Galapagos NV | 1.91B | -1.58% | 106,455 | 1.31B |
| 108 | NTLA | Intellia Therapeutics, Inc. | 1.87B | -4.22% | 5,493,787 | 67.67M |
| 109 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 0.34% | 1,303,294 | 868.45M |
| 110 | SNDX | Syndax Pharmaceuticals, Inc. | 1.85B | -4.89% | 2,488,177 | 172.35M |
| 111 | RXRX | Recursion Pharmaceuticals, Inc. | 1.85B | -6.17% | 11,271,107 | 74.68M |
| 112 | TSHA | Taysha Gene Therapies, Inc. | 1.84B | -4.76% | 2,254,150 | 9.77M |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.82B | -2.75% | 149,151 | - |
| 114 | PHVS | Pharvaris N.V. | 1.78B | -9.15% | 265,658 | - |
| 115 | NUVB | Nuvation Bio Inc. | 1.75B | -1.56% | 2,151,736 | 62.90M |
| 116 | VCEL | Vericel Corporation | 1.75B | 0.09% | 459,815 | 276.26M |
| 117 | INBX | Inhibrx Biosciences, Inc. | 1.75B | 4.21% | 955,908 | 1.30M |
| 118 | ATAI | AtaiBeckley Inc. | 1.74B | 1.27% | 8,475,430 | 4.09M |
| 119 | INVA | Innoviva, Inc. | 1.74B | -0.09% | 387,159 | 411.33M |
| 120 | RAPP | Rapport Therapeutics, Inc. | 1.74B | -1.14% | 314,759 | - |
| 121 | SION | Sionna Therapeutics, Inc. | 1.73B | -11.23% | 449,480 | - |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.71B | -0.36% | 921,530 | 71.78M |
| 123 | VIR | Vir Biotechnology, Inc. | 1.67B | -3.00% | 1,241,388 | 68.56M |
| 124 | GENB | Generate Biomedicines, Inc. | 1.64B | -1.30% | 323,352 | 31.89M |
| 125 | NBTX | Nanobiotix S.A. | 1.63B | 4.69% | 84,694 | 38.27M |
| 126 | GLUE | Monte Rosa Therapeutics, Inc. | 1.61B | -3.86% | 853,617 | 123.67M |
| 127 | MBX | MBX Biosciences, Inc. | 1.59B | -0.57% | 557,306 | - |
| 128 | OCS | Oculis Holding AG | 1.58B | -3.88% | 415,793 | 1.51M |
| 129 | BHVN | Biohaven Ltd. | 1.58B | -1.50% | 1,439,212 | - |
| 130 | DMRA | Damora Therapeutics, Inc. | 1.53B | -1.85% | 119,458 | - |
| 131 | AGIO | Agios Pharmaceuticals, Inc. | 1.51B | -3.67% | 1,020,357 | 54.03M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.50B | -3.34% | 467,042 | - |
| 133 | IMTX | Immatics N.V. | 1.50B | -0.98% | 364,941 | 56.67M |
| 134 | IMCR | Immunocore Holdings plc | 1.49B | -2.50% | 336,354 | 400.02M |
| 135 | ANAB | AnaptysBio, Inc. | 1.47B | -4.26% | 409,357 | 234.60M |
| 136 | VRDN | Viridian Therapeutics, Inc. | 1.47B | -0.70% | 1,269,036 | 70.85M |
| 137 | ARDX | Ardelyx, Inc. | 1.46B | -1.00% | 2,031,873 | 407.32M |
| 138 | MAZE | Maze Therapeutics, Inc. | 1.44B | -1.85% | 583,672 | 2.50M |
| 139 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | -1.42% | 15,322,919 | 263.50M |
| 140 | WVE | Wave Life Sciences Ltd. | 1.41B | -0.95% | 2,563,883 | 42.73M |
| 141 | PGEN | Precigen, Inc. | 1.40B | - | 4,996,132 | 9.68M |
| 142 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 0.32% | 455,805 | - |
| 143 | CRVS | Corvus Pharmaceuticals, Inc. | 1.35B | -10.25% | 2,326,648 | - |
| 144 | OLMA | Olema Pharmaceuticals, Inc. | 1.34B | -5.48% | 723,184 | - |
| 145 | NVAX | Novavax, Inc. | 1.33B | -3.55% | 3,580,280 | 1.12B |
| 146 | MPLT | MapLight Therapeutics, Inc. | 1.28B | -9.40% | 561,921 | - |
| 147 | SVRA | Savara Inc. | 1.25B | -3.89% | 1,825,360 | - |
| 148 | JBIO | Jade Biosciences, Inc. | 1.24B | -0.67% | 683,897 | - |
| 149 | ABCL | AbCellera Biologics Inc. | 1.23B | -0.74% | 8,164,607 | 75.13M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.22B | 0.36% | 270,532 | 6.50M |
| 151 | MLTX | MoonLake Immunotherapeutics | 1.21B | -1.68% | 640,099 | - |
| 152 | PHAR | Pharming Group N.V. | 1.20B | -2.58% | 5,092 | 376.13M |
| 153 | URGN | UroGen Pharma Ltd. | 1.18B | -6.72% | 927,137 | 109.79M |
| 154 | GHRS | GH Research PLC | 1.17B | -0.74% | 294,000 | - |
| 155 | DBVT | DBV Technologies S.A. | 1.16B | -1.53% | 163,700 | 5.64M |
| 156 | EYPT | EyePoint, Inc. | 1.15B | -2.81% | 685,313 | 31.37M |
| 157 | SEPN | Septerna, Inc. | 1.12B | -3.44% | 347,313 | 45.95M |
| 158 | QURE | uniQure N.V. | 1.11B | -1.35% | 725,947 | 16.10M |
| 159 | ZBIO | Zenas BioPharma, Inc. | 1.10B | -7.87% | 532,185 | 10.00M |
| 160 | IVA | Inventiva S.A. | 1.09B | -0.76% | 161,177 | 7.94M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.05B | -3.16% | 1,091,219 | - |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 1.03B | -1.49% | 1,143,002 | 291.85M |
| 163 | ANNX | Annexon, Inc. | 984.79M | -3.19% | 2,087,384 | - |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 977.33M | -2.45% | 1,674,698 | 73.62M |
| 165 | OMER | Omeros Corporation | 973.39M | 1.12% | 869,163 | - |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 965.87M | 3.67% | 1,251,601 | 175.11M |
| 167 | CTMX | CytomX Therapeutics, Inc. | 961.99M | -3.47% | 3,360,757 | 76.20M |
| 168 | GERN | Geron Corporation | 961.35M | -3.23% | 8,988,733 | 183.88M |
| 169 | SANA | Sana Biotechnology, Inc. | 943.85M | -6.78% | 2,883,334 | - |
| 170 | CMPX | Compass Therapeutics, Inc. | 938.26M | -2.07% | 1,079,628 | 850.00K |
| 171 | EVMN | Evommune, Inc. | 930.71M | -4.72% | 180,655 | 13.00M |
| 172 | JANX | Janux Therapeutics, Inc. | 924.03M | -1.30% | 572,521 | 10.00M |
| 173 | XNCR | Xencor, Inc. | 913.07M | -3.11% | 335,047 | 125.58M |
| 174 | ANRO | Alto Neuroscience, Inc. | 901.21M | -5.34% | 230,090 | - |
| 175 | FTRE | Fortrea Holdings Inc. | 900.41M | -8.29% | 1,754,727 | 2.72B |
| 176 | MRVI | Maravai LifeSciences Holdings, Inc. | 886.88M | -6.50% | 1,899,830 | 185.74M |
| 177 | LBRX | LB Pharmaceuticals Inc | 882.47M | -3.16% | 172,808 | - |
| 178 | DRUG | Bright Minds Biosciences Inc. | 870.01M | -1.63% | 191,619 | - |
| 179 | MGTX | MeiraGTx Holdings plc | 862.63M | -7.08% | 1,033,361 | 81.39M |
| 180 | CBIO | Crescent Biopharma, Inc. | 853.60M | -4.74% | 417,336 | 10.84M |
| 181 | TBPH | Theravance Biopharma, Inc. | 839.85M | -1.57% | 300,420 | 107.46M |
| 182 | ABUS | Arbutus Biopharma Corporation | 836.99M | -4.06% | 4,998,949 | 14.08M |
| 183 | MNKD | MannKind Corporation | 836.84M | -1.09% | 2,944,509 | 348.97M |
| 184 | SLS | SELLAS Life Sciences Group, Inc. | 833.26M | -2.93% | 4,413,072 | - |
| 185 | SPRY | ARS Pharmaceuticals, Inc. | 824.17M | -1.19% | 2,520,964 | 84.28M |
| 186 | KURA | Kura Oncology, Inc. | 822.83M | -2.73% | 993,063 | 67.48M |
| 187 | SLDB | Solid Biosciences Inc. | 808.80M | -2.14% | 531,450 | - |
| 188 | ALLO | Allogene Therapeutics, Inc. | 808.35M | -1.67% | 9,378,939 | 22.00K |
| 189 | VOR | Vor Biopharma Inc. | 792.19M | -4.57% | 972,046 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 789.87M | -3.51% | 90,635 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 788.17M | -4.41% | 548,594 | - |
| 192 | CGEM | Cullinan Therapeutics, Inc. | 783.81M | -6.43% | 536,010 | - |
| 193 | RLMD | Relmada Therapeutics, Inc. | 760.44M | 2.69% | 744,999 | - |
| 194 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 717.89M | 1.13% | 395,214 | - |
| 195 | LXRX | Lexicon Pharmaceuticals, Inc. | 711.78M | -7.69% | 2,208,152 | 49.80M |
| 196 | FBRX | Forte Biosciences, Inc. | 706.44M | -3.25% | 242,462 | - |
| 197 | TENX | Tenax Therapeutics, Inc. | 702.70M | 0.36% | 276,635 | - |
| 198 | DRTS | Alpha Tau Medical Ltd. | 702.32M | -1.24% | 365,765 | - |
| 199 | PRME | Prime Medicine, Inc. | 679.99M | -3.03% | 1,841,772 | 4.63M |
| 200 | GYRE | Gyre Therapeutics, Inc. | 679.38M | -3.75% | 46,638 | 116.59M |
| 201 | ARVN | Arvinas, Inc. | 666.47M | -1.98% | 557,723 | 262.60M |
| 202 | TRAX | First Tracks Biotherapeutics, Inc. | 660.23M | 0.69% | 519,953 | - |
| 203 | ACRS | Aclaris Therapeutics, Inc. | 632.43M | 3.64% | 1,993,540 | 7.83M |
| 204 | ABSI | Absci Corporation | 607.49M | 7.88% | 4,051,731 | 2.80M |
| 205 | PROK | ProKidney Corp. | 603.92M | -4.31% | 516,185 | 893.00K |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 597.65M | -3.62% | 638,647 | 106.47M |
| 207 | ANL | Adlai Nortye Ltd. | 596.40M | -7.56% | 427,705 | 5.00M |
| 208 | EIKN | Eikon Therapeutics, Inc. | 579.28M | -7.76% | 152,031 | - |
| 209 | STTK | Shattuck Labs, Inc. | 578.20M | -1.29% | 306,178 | 1.00M |
| 210 | PRTA | Prothena Corporation plc | 577.63M | 0.09% | 474,684 | 9.68M |
| 211 | STRO | Sutro Biopharma, Inc. | 577.04M | -1.97% | 277,874 | 102.48M |
| 212 | CRMD | CorMedix Inc. | 574.88M | -2.14% | 755,147 | 311.71M |
| 213 | RIGL | Rigel Pharmaceuticals, Inc. | 567.71M | 0.82% | 178,640 | 294.28M |
| 214 | OCGN | Ocugen, Inc. | 565.32M | -0.60% | 5,548,510 | 4.41M |
| 215 | LYEL | Lyell Immunopharma, Inc. | 550.55M | -4.76% | 80,604 | 36.00K |
| 216 | VSTM | Verastem, Inc. | 547.26M | 2.64% | 2,415,819 | 30.91M |
| 217 | ENGN | enGene Therapeutics Inc. | 545.29M | -4.68% | 450,000 | - |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 541.75M | -12.51% | 2,197,329 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 539.13M | -0.10% | 385,494 | - |
| 220 | FULC | Fulcrum Therapeutics, Inc. | 538.13M | 4.26% | 718,507 | 80.00M |
| 221 | TECX | Tectonic Therapeutic, Inc. | 534.01M | -0.21% | 335,820 | - |
| 222 | ZURA | Zura Bio Limited | 523.74M | -2.99% | 500,694 | - |
| 223 | UPB | Upstream Bio, Inc. | 522.43M | -0.41% | 427,994 | 2.85M |
| 224 | AGMB | AgomAb Therapeutics NV | 521.48M | 1.42% | 84,761 | - |
| 225 | CADL | Candel Therapeutics, Inc. | 515.66M | -4.09% | 2,260,469 | - |
| 226 | ADCT | ADC Therapeutics SA | 503.67M | -3.18% | 640,291 | 81.36M |
| 227 | MDXG | MiMedx Group, Inc. | 497.70M | 1.21% | 1,751,607 | 418.63M |
| 228 | ARMP | Armata Pharmaceuticals, Inc. | 495.64M | -2.73% | 29,650 | 4.90M |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 490.60M | -1.94% | 535,238 | 85.21M |
| 230 | VALN | Valneva SE | 487.45M | 1.52% | 310,160 | 205.07M |
| 231 | LRMR | Larimar Therapeutics, Inc. | 467.47M | -1.32% | 1,201,919 | - |
| 232 | AURA | Aura Biosciences, Inc. | 465.73M | -3.07% | 296,110 | - |
| 233 | RGNX | REGENXBIO Inc. | 464.04M | -3.75% | 483,732 | 170.44M |
| 234 | CTNM | Contineum Therapeutics, Inc. | 463.71M | -4.17% | 94,237 | - |
| 235 | TRDA | Entrada Therapeutics, Inc. | 461.16M | -1.84% | 164,038 | 25.42M |
| 236 | XOMA | XOMA Royalty Corporation | 451.49M | -3.76% | 67,348 | 52.15M |
| 237 | ASMB | Assembly Biosciences, Inc. | 449.39M | 0.11% | 78,969 | 72.30M |
| 238 | EPRX | Eupraxia Pharmaceuticals Inc. | 449.08M | 2.69% | 192,559 | - |
| 239 | DNA | Ginkgo Bioworks Holdings, Inc. | 448.20M | -8.77% | 870,091 | 170.16M |
| 240 | LXEO | Lexeo Therapeutics, Inc. | 445.26M | -5.06% | 1,077,671 | - |
| 241 | PRLD | Prelude Therapeutics Incorporated | 442.43M | 2.09% | 717,329 | 12.14M |
| 242 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | -1.60% | 146,622 | - |
| 243 | BNTC | Benitec Biopharma Inc. | 435.04M | -2.01% | 115,673 | - |
| 244 | VTVT | vTv Therapeutics Inc. | 432.47M | -13.84% | 88,499 | 17.00K |
| 245 | CLYM | Climb Bio, Inc. | 430.87M | -3.01% | 488,017 | - |
| 246 | IVVD | Invivyd, Inc. | 427.03M | -5.63% | 1,451,812 | 53.43M |
| 247 | NGNE | Neurogene Inc. | 420.85M | -1.17% | 134,617 | 925.00K |
| 248 | PRTC | PureTech Health plc | 413.57M | -0.50% | 9,742 | 6.39M |
| 249 | NMRA | Neumora Therapeutics, Inc. | 407.39M | -3.46% | 1,186,875 | - |
| 250 | AUTL | Autolus Therapeutics plc | 407.20M | -4.38% | 1,294,447 | 75.39M |
| 251 | IPSC | Century Therapeutics, Inc. | 406.93M | -7.57% | 776,673 | 109.16M |
| 252 | RCKT | Rocket Pharmaceuticals, Inc. | 401.57M | -3.16% | 1,611,294 | - |
| 253 | IMRX | Immuneering Corporation | 396.32M | 4.07% | 932,043 | - |
| 254 | VNDA | Vanda Pharmaceuticals Inc. | 395.43M | -2.05% | 1,334,397 | 216.11M |
| 255 | AVTX | Avalo Therapeutics, Inc. | 394.04M | 1.72% | 655,823 | 59.00K |
| 256 | XFOR | X4 Pharmaceuticals, Inc. | 389.14M | -3.17% | 635,204 | 35.11M |
| 257 | LCTX | Lineage Cell Therapeutics, Inc. | 388.58M | -4.29% | 1,052,494 | 14.56M |
| 258 | ENTA | Enanta Pharmaceuticals, Inc. | 387.41M | -3.19% | 90,128 | 66.98M |
| 259 | NAGE | Niagen Bioscience, Inc. | 379.57M | -5.78% | 773,331 | 129.42M |
| 260 | PBYI | Puma Biotechnology, Inc. | 376.49M | -0.40% | 239,071 | 228.37M |
| 261 | ALT | Altimmune, Inc. | 376.00M | -16.71% | 30,489,039 | 41.00K |
| 262 | IRD | Opus Genetics, Inc. | 370.69M | -4.75% | 1,133,404 | 14.20M |
| 263 | SLN | Silence Therapeutics plc | 370.31M | -1.63% | 568,119 | 559.00K |
| 264 | YDES | YD Bio Limited | 368.83M | -1.41% | 7,086 | 510.36K |
| 265 | PALI | Palisade Bio, Inc. | 363.31M | -7.26% | 9,371,422 | - |
| 266 | MNPR | Monopar Therapeutics Inc. | 356.29M | -0.11% | 198,338 | - |
| 267 | OVID | Ovid Therapeutics Inc. | 353.42M | 0.75% | 1,833,364 | 7.25M |
| 268 | SRZN | Surrozen, Inc. | 351.90M | -7.25% | 158,121 | 3.48M |
| 269 | CABA | Cabaletta Bio, Inc. | 339.53M | -3.79% | 1,427,457 | - |
| 270 | BCYC | Bicycle Therapeutics plc | 338.08M | -2.81% | 371,044 | 72.59M |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 335.15M | -3.86% | 131,276 | - |
| 272 | IKT | Inhibikase Therapeutics, Inc. | 328.92M | 6.04% | 1,027,264 | 1.00 |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 327.94M | -5.09% | 79,432 | - |
| 274 | NAUT | Nautilus Biotechnology, Inc. | 326.54M | -10.10% | 331,711 | - |
| 275 | RZLT | Rezolute, Inc. | 323.04M | -6.61% | 1,034,754 | - |
| 276 | NGEN | NervGen Pharma Corp. | 318.06M | -2.36% | 87,195 | - |
| 277 | EDIT | Editas Medicine, Inc. | 314.17M | -3.60% | 1,195,733 | 40.52M |
| 278 | ABEO | Abeona Therapeutics Inc. | 313.99M | -1.95% | 678,852 | 5.82M |
| 279 | AVXL | Anavex Life Sciences Corp. | 306.74M | -8.31% | 986,931 | - |
| 280 | FHTX | Foghorn Therapeutics Inc. | 304.65M | -3.71% | 81,462 | 30.91M |
| 281 | NERV | Minerva Neurosciences, Inc. | 299.44M | -7.07% | 97,035 | - |
| 282 | ACIU | AC Immune SA | 294.63M | -2.94% | 264,449 | 4.51M |
| 283 | CCCC | C4 Therapeutics, Inc. | 289.81M | -3.26% | 2,286,243 | 35.95M |
| 284 | HELP | Cybin Inc. | 287.71M | -0.35% | 2,037,583 | - |
| 285 | LENZ | LENZ Therapeutics, Inc. | 286.89M | -8.41% | 950,170 | 19.09M |
| 286 | NBP | NovaBridge Biosciences | 285.65M | -4.26% | 322,884 | - |
| 287 | TARA | Protara Therapeutics, Inc. | 284.48M | -2.77% | 1,176,764 | - |
| 288 | CLLS | Cellectis S.A. | 284.00M | -1.76% | 10,031 | 79.59M |
| 289 | ARTV | Artiva Biotherapeutics, Inc. | 279.30M | -3.67% | 172,467 | 251.00K |
| 290 | CGEN | Compugen Ltd. | 276.10M | 3.18% | 582,048 | 72.76M |
| 291 | ZNTL | Zentalis Pharmaceuticals, Inc. | 275.92M | 1.30% | 1,430,277 | 26.87M |
| 292 | ELDN | Eledon Pharmaceuticals, Inc. | 272.72M | -10.03% | 2,695,944 | - |
| 293 | CHRS | Coherus Oncology, Inc. | 271.42M | -2.22% | 1,379,828 | 42.17M |
| 294 | ALEC | Alector, Inc. | 268.18M | -0.82% | 303,384 | 21.05M |
| 295 | SABS | SAB Biotherapeutics, Inc. | 267.05M | -4.76% | 467,591 | 114.70K |
| 296 | PLYX | Polaryx Therapeutics, Inc. | 251.87M | -3.45% | 84,883 | - |
| 297 | ADAG | Adagene Inc. | 247.11M | -1.06% | 95,227 | 7.67M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 242.86M | -1.43% | 128,397 | 33.48M |
| 299 | VYGR | Voyager Therapeutics, Inc. | 240.78M | -2.42% | 323,233 | 40.37M |
| 300 | ARCT | Arcturus Therapeutics Holdings Inc. | 240.74M | -1.74% | 256,452 | 82.03M |
| 301 | SLGL | Sol-Gel Technologies Ltd. | 236.35M | -1.61% | 53,519 | 19.39M |
| 302 | REPL | Replimune Group, Inc. | 235.33M | 25.55% | 19,336,723 | - |
| 303 | NVCT | Nuvectis Pharma, Inc. | 232.86M | -0.34% | 34,893 | - |
| 304 | CAMP | Camp4 Therapeutics Corporation | 230.52M | -2.63% | 29,315 | 3.50M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 229.60M | -0.30% | 47,586 | 44.64M |
| 306 | MIST | Milestone Pharmaceuticals Inc. | 229.35M | -6.97% | 1,445,689 | 1.55M |
| 307 | CDXS | Codexis, Inc. | 228.99M | 2.02% | 1,106,060 | 70.39M |
| 308 | KROS | Keros Therapeutics, Inc. | 227.93M | 1.05% | 252,593 | 244.06M |
| 309 | OABI | OmniAb, Inc. | 225.86M | 4.00% | 527,021 | 18.67M |
| 310 | ACHV | Achieve Life Sciences, Inc. | 220.95M | -1.89% | 1,211,585 | - |
| 311 | CRBU | Caribou Biosciences, Inc. | 218.40M | -4.24% | 1,472,397 | 11.16M |
| 312 | ELTX | Elicio Therapeutics, Inc. | 217.99M | -1.09% | 72,191 | - |
| 313 | ENLV | Enlivex Ltd. | 215.23M | 2.04% | 497,727 | - |
| 314 | MDWD | MediWound Ltd. | 213.99M | -2.52% | 66,027 | 16.96M |
| 315 | CNTX | Context Therapeutics Inc. | 213.16M | -3.73% | 1,211,283 | - |
| 316 | NKTX | Nkarta, Inc. | 212.45M | -3.56% | 1,050,646 | - |
| 317 | ALXO | ALX Oncology Holdings Inc. | 209.26M | -6.47% | 1,299,411 | - |
| 318 | MGNX | MacroGenics, Inc. | 202.12M | -7.02% | 565,572 | 149.50M |
| 319 | KPTI | Karyopharm Therapeutics Inc. | 197.25M | -8.38% | 545,797 | 146.07M |
| 320 | WHWK | Whitehawk Therapeutics, Inc. | 196.81M | -1.42% | 146,679 | 7.15M |
| 321 | KRRO | Korro Bio, Inc. | 196.07M | -2.82% | 54,723 | 6.39M |
| 322 | ABOS | Acumen Pharmaceuticals, Inc. | 192.81M | -4.98% | 300,613 | - |
| 323 | SGMT | Sagimet Biosciences Inc. | 191.27M | -6.53% | 203,121 | - |
| 324 | CNTN | Canton Strategic Holdings, Inc. | 190.93M | -5.07% | 281,678 | - |
| 325 | DTIL | Precision BioSciences, Inc. | 188.62M | -7.59% | 161,110 | 34.26M |
| 326 | HRTX | Heron Therapeutics, Inc. | 188.50M | -1.98% | 1,973,073 | 154.90M |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 185.50M | -4.67% | 419,765 | - |
| 328 | RNAC | Cartesian Therapeutics, Inc. | 184.77M | 1.16% | 93,317 | 2.80M |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 181.27M | -2.48% | 260,332 | - |
| 330 | BDTX | Black Diamond Therapeutics, Inc. | 177.60M | -7.46% | 1,047,548 | 70.00M |
| 331 | TNXP | Tonix Pharmaceuticals Holding Corp. | 177.43M | -4.73% | 372,485 | 13.11M |
| 332 | MENS | Jyong Biotech Ltd. | 174.56M | -0.44% | 70,944 | - |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 172.42M | -2.73% | 856,060 | 52.74M |
| 334 | PRQR | ProQR Therapeutics N.V. | 171.74M | -6.86% | 711,753 | 19.19M |
| 335 | SPRO | Spero Therapeutics, Inc. | 162.10M | -2.10% | 297,031 | 66.80M |
| 336 | MOLN | Molecular Partners AG | 160.89M | 1.38% | 2,177 | 856.30K |
| 337 | HUMA | Humacyte, Inc. | 157.21M | 0.45% | 4,523,661 | 2.04M |
| 338 | TLSA | Tiziana Life Sciences Ltd | 156.98M | -0.81% | 197,277 | - |
| 339 | GALT | Galectin Therapeutics Inc. | 156.01M | -3.27% | 168,212 | - |
| 340 | ORMP | Oramed Pharmaceuticals Inc. | 155.31M | -1.54% | 95,007 | 2.00M |
| 341 | ANTX | AN2 Therapeutics, Inc. | 154.02M | 7.00% | 199,688 | - |
| 342 | FATE | Fate Therapeutics, Inc. | 153.47M | -3.65% | 990,831 | 6.65M |
| 343 | ALPS | Alps Group Inc | 152.26M | -2.66% | 16,204 | 3.74M |
| 344 | ACOG | Alpha Cognition Inc. | 149.15M | -2.00% | 55,142 | 10.22M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 148.41M | -7.09% | 3,795,035 | - |
| 346 | SPRB | Spruce Biosciences, Inc. | 145.95M | 3.15% | 92,385 | 697.00K |
| 347 | HURA | TuHURA Biosciences, Inc. | 145.59M | -14.55% | 1,669,571 | - |
| 348 | AGEN | Agenus Inc. | 144.38M | -4.57% | 840,267 | 114.20M |
| 349 | KALA | KALA BIO, Inc. | 143.14M | -12.75% | 3,612,010 | - |
| 350 | CNTB | Connect Biopharma Holdings Limited | 142.43M | -3.08% | 233,127 | 64.00K |
| 351 | KLRS | Kalaris Therapeutics, Inc. | 139.86M | -3.63% | 32,917 | - |
| 352 | EQ | Equillium, Inc. | 137.20M | -6.87% | 403,716 | 4.39M |
| 353 | BMEA | Biomea Fusion, Inc. | 135.20M | 1.08% | 1,167,701 | - |
| 354 | KZIA | Kazia Therapeutics Limited | 135.07M | 2.52% | 271,774 | 1.27M |
| 355 | IPHA | Innate Pharma S.A. | 126.83M | -4.20% | 4,739 | 10.57M |
| 356 | ONCY | Oncolytics Biotech Inc. | 126.58M | -5.22% | 736,406 | - |
| 357 | IMUX | Immunic, Inc. | 119.81M | 2.03% | 5,809,393 | - |
| 358 | NTHI | NeOnc Technologies Holdings, Inc. | 119.33M | -3.23% | 69,375 | 39.99K |
| 359 | AARD | Aardvark Therapeutics, Inc. | 117.15M | -2.89% | 83,542 | - |
| 360 | CRDF | Cardiff Oncology, Inc. | 114.17M | -3.47% | 395,132 | 593.00K |
| 361 | IFRX | InflaRx N.V. | 112.78M | -2.50% | 1,028,960 | 34.44K |
| 362 | CGTX | Cognition Therapeutics, Inc. | 112.59M | -2.33% | 1,259,831 | - |
| 363 | GNLX | Genelux Corporation | 111.82M | -0.79% | 151,664 | 8.00K |
| 364 | VRCA | Verrica Pharmaceuticals Inc. | 111.49M | -0.31% | 81,724 | 35.58M |
| 365 | VANI | Vivani Medical, Inc. | 110.89M | -1.50% | 216,597 | - |
| 366 | CBUS | Cibus, Inc. | 110.45M | -2.68% | 1,208,126 | 3.64M |
| 367 | PEPG | PepGen Inc. | 109.89M | -4.22% | 1,296,789 | - |
| 368 | SEER | Seer, Inc. | 109.46M | -2.02% | 222,195 | 16.58M |
| 369 | PYXS | Pyxis Oncology, Inc. | 107.44M | -9.04% | 264,356 | 13.86M |
| 370 | SGMO | Sangamo Therapeutics, Inc. | 105.64M | -1.12% | 7,131,057 | 39.55M |
| 371 | ANIX | Anixa Biosciences, Inc. | 101.92M | -3.18% | 122,294 | - |
| 372 | COYA | Coya Therapeutics, Inc. | 101.80M | -1.59% | 174,969 | 7.95M |
| 373 | COEP | Coeptis Therapeutics Holdings, Inc. | 100.88M | 7.35% | 96,892 | 1.36M |
| 374 | TTRX | Turn Therapeutics Inc. | 99.79M | -1.76% | 7,767 | - |
| 375 | PMN | ProMIS Neurosciences, Inc. | 97.57M | -2.07% | 20,576 | - |
| 376 | ALDX | Aldeyra Therapeutics, Inc. | 96.29M | -5.88% | 1,510,645 | - |
| 377 | QTTB | Q32 Bio Inc. | 94.80M | -2.56% | 210,351 | 53.74M |
| 378 | NRXP | NRx Pharmaceuticals, Inc. | 93.82M | -4.38% | 810,871 | 1.23M |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 93.41M | - | 691,374 | 65.34K |
| 380 | GUTS | Fractyl Health, Inc. | 92.18M | -1.61% | 1,192,780 | 3.00K |
| 381 | RANI | Rani Therapeutics Holdings, Inc. | 91.38M | -3.63% | 560,391 | 1.63M |
| 382 | PYPD | PolyPid Ltd. | 88.55M | -1.49% | 68,820 | - |
| 383 | GOSS | Gossamer Bio, Inc. | 87.68M | -4.18% | 4,196,398 | 48.47M |
| 384 | EXOZ | eXoZymes, Inc. | 87.42M | -1.81% | 709 | -700.00 |
| 385 | ACET | Adicet Bio, Inc. | 84.92M | -4.93% | 76,889 | - |
| 386 | CSBR | Champions Oncology, Inc. | 83.88M | 0.50% | 5,373 | 57.95M |
| 387 | OKYO | OKYO Pharma Limited | 83.44M | -1.85% | 171,624 | - |
| 388 | NRXS | NeurAxis, Inc. | 83.35M | -0.80% | 158,715 | 3.57M |
| 389 | LONA | LeonaBio, Inc. | 80.97M | -5.90% | 58,303 | - |
| 390 | FLNA | Filana Therapeutics, Inc. | 80.19M | -1.78% | 377,028 | - |
| 391 | GANX | Gain Therapeutics, Inc. | 79.84M | -7.35% | 583,763 | - |
| 392 | IMMP | Immutep Limited | 78.10M | -3.65% | 2,770,583 | 5.28M |
| 393 | PLRX | Pliant Therapeutics, Inc. | 78.01M | -2.33% | 433,092 | - |
| 394 | PTHS | Pelthos Therapeutics Inc. | 77.85M | 0.87% | 12,120 | 16.80M |
| 395 | ATYR | aTyr Pharma, Inc. | 77.63M | -6.23% | 836,666 | 190.00K |
| 396 | MCRB | Seres Therapeutics, Inc. | 77.55M | -4.15% | 44,674 | 789.00K |
| 397 | XBIT | XBiotech Inc. | 77.13M | - | 24,085 | - |
| 398 | MAIA | MAIA Biotechnology, Inc. | 76.45M | -7.35% | 530,418 | - |
| 399 | PMVP | PMV Pharmaceuticals, Inc. | 76.26M | -3.38% | 484,777 | - |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 73.23M | -4.06% | 531,609 | - |
| 401 | ESLA | Estrella Immunopharma, Inc. | 72.96M | -5.00% | 68,303 | - |
| 402 | ICCC | ImmuCell Corporation | 72.37M | 2.30% | 9,556 | 27.64M |
| 403 | TCRX | TScan Therapeutics, Inc. | 72.12M | -4.00% | 1,266,058 | 10.33M |
| 404 | FBIO | Fortress Biotech, Inc. | 71.81M | -0.89% | 291,567 | 63.26M |
| 405 | IBO | Impact BioMedical Inc. | 70.62M | -0.82% | 48,961 | 32.00K |
| 406 | ATHE | Alterity Therapeutics Limited | 70.10M | -3.74% | 15,142 | 4.43M |
| 407 | BYSI | BeyondSpring Inc. | 68.26M | 1.84% | 7,016 | 1.88M |
| 408 | MNOV | MediciNova, Inc. | 67.43M | -2.84% | 21,890 | 409.66K |
| 409 | OKUR | OnKure Therapeutics, Inc. | 67.00M | -2.20% | 108,652 | - |
| 410 | IMA | ImageneBio, Inc. | 65.54M | -2.50% | 35,240 | 800.00K |
| 411 | IBIO | iBio, Inc. | 65.42M | -5.73% | 1,266,851 | 300.00K |
| 412 | CING | Cingulate Inc. | 65.35M | 0.18% | 536,901 | - |
| 413 | ANVS | Annovis Bio, Inc. | 62.50M | -1.63% | 1,119,201 | - |
| 414 | OSTX | OS Therapies Incorporated | 60.96M | 1.40% | 495,251 | - |
| 415 | EDSA | Edesa Biotech, Inc. | 60.25M | -3.56% | 171,636 | - |
| 416 | ACTU | Actuate Therapeutics, Inc. | 59.99M | -8.99% | 202,802 | - |
| 417 | HYFT | MindWalk Holdings Corp. | 59.60M | -7.69% | 115,649 | 20.70M |
| 418 | TIL | Instil Bio, Inc. | 55.48M | -2.73% | 9,493 | - |
| 419 | ENTX | Entera Bio Ltd. | 54.55M | -4.10% | 110,703 | 42.00K |
| 420 | CUE | Cue Biopharma, Inc. | 54.12M | 2,766.06% | 82,369 | 27.47M |
| 421 | MGX | Metagenomi Therapeutics, Inc. | 53.80M | -3.38% | 157,478 | 25.21M |
| 422 | KZR | Kezar Life Sciences, Inc. | 53.71M | -0.41% | 90,764 | - |
| 423 | INKT | MiNK Therapeutics, Inc. | 53.28M | -5.38% | 44,684 | - |
| 424 | PDSB | PDS Biotechnology Corporation | 51.80M | -28.05% | 2,123,625 | - |
| 425 | RNTX | Rein Therapeutics Inc. | 51.59M | -2.13% | 70,615 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 50.77M | -2.48% | 37,120 | 10.86M |
| 427 | PSTV | Plus Therapeutics, Inc. | 49.96M | -4.46% | 214,603 | 5.21M |
| 428 | ATOS | Atossa Therapeutics, Inc. | 49.34M | -3.70% | 39,354 | - |
| 429 | XLO | Xilio Therapeutics, Inc. | 48.98M | -1.51% | 28,115 | 43.77M |
| 430 | MREO | Mereo BioPharma Group plc | 48.94M | -4.60% | 1,235,510 | 500.00K |
| 431 | NTRB | Nutriband Inc. | 48.75M | -3.84% | 7,405 | 2.28M |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 47.45M | 0.73% | 82,476 | - |
| 433 | DWTX | Dogwood Therapeutics, Inc. | 46.76M | -8.50% | 397,345 | - |
| 434 | LIXT | Lixte Biotechnology Holdings, Inc. | 46.24M | 3.92% | 119,658 | - |
| 435 | RLYB | Rallybio Corporation | 44.96M | -0.58% | 17,108 | 858.00K |
| 436 | HYPD | Hyperion DeFi, Inc. | 44.77M | -1.26% | 109,717 | 813.46K |
| 437 | NXTC | NextCure, Inc. | 44.15M | 3.33% | 118,721 | - |
| 438 | SNSE | Sensei Biotherapeutics, Inc. | 43.72M | 3.10% | 25,815 | - |
| 439 | LITS | Lite Strategy, Inc. | 42.91M | -0.84% | 247,054 | - |
| 440 | HOWL | Werewolf Therapeutics, Inc. | 41.80M | -7.76% | 150,183 | 1.14M |
| 441 | ATNM | Actinium Pharmaceuticals, Inc. | 40.84M | -6.43% | 204,020 | 90.00K |
| 442 | RNXT | RenovoRx, Inc. | 40.55M | -5.09% | 376,296 | 1.12M |
| 443 | ATRA | Atara Biotherapeutics, Inc. | 40.07M | -5.41% | 34,647 | 120.77M |
| 444 | ALGS | Aligos Therapeutics, Inc. | 37.93M | -5.84% | 256,582 | 2.19M |
| 445 | VERU | Veru Inc. | 37.08M | -5.33% | 66,488 | 16.89M |
| 446 | INMB | INmune Bio Inc. | 36.69M | -3.50% | 142,302 | 50.00K |
| 447 | GRCE | Grace Therapeutics, Inc. | 36.36M | -45.48% | 6,546,727 | - |
| 448 | PTN | Palatin Technologies, Inc. | 36.33M | -7.97% | 10,485 | 8.96M |
| 449 | CRVO | CervoMed Inc. | 35.65M | -2.28% | 43,209 | 4.01M |
| 450 | EVAX | Evaxion A/S | 35.45M | -0.47% | 40,134 | 7.53M |
| 451 | PLUR | Pluri Inc. | 34.57M | 2.69% | 5,668 | 1.34M |
| 452 | BOLD | Boundless Bio, Inc. | 34.06M | -1.94% | 95,677 | - |
| 453 | IGC | IGC Pharma, Inc. | 32.55M | -3.22% | 1,665,696 | 1.11M |
| 454 | CELU | Celularity Inc. | 32.30M | -4.27% | 75,038 | 40.58M |
| 455 | SKYE | Skye Bioscience, Inc. | 31.57M | -0.13% | 270,000 | - |
| 456 | DYAI | Dyadic International, Inc. | 31.56M | 4.34% | 34,860 | 3.09M |
| 457 | SNTI | Senti Biosciences, Inc. | 31.46M | -11.40% | 270,737 | 22.00K |
| 458 | DARE | Daré Bioscience, Inc. | 30.87M | -6.61% | 555,750 | 1.03M |
| 459 | LSTA | Lisata Therapeutics, Inc. | 30.08M | -2.63% | 93,360 | 170.00K |
| 460 | OTLK | Outlook Therapeutics, Inc. | 30.01M | -1.14% | 4,089,834 | 205.70K |
| 461 | TVGN | Tevogen Bio Holdings Inc. | 29.19M | -13.88% | 19,323 | - |
| 462 | LGVN | Longeveron Inc. | 28.59M | -5.20% | 544,177 | 1.20M |
| 463 | APLM | Apollomics, Inc. | 28.43M | -1.85% | 1,395 | 6.93M |
| 464 | KYNB | Kyntra Bio, Inc. | 28.37M | -2.49% | 4,208 | 6.44M |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 28.24M | -6.81% | 36,680 | - |
| 466 | ABVC | ABVC BioPharma, Inc. | 28.17M | -3.39% | 49,807 | 797.92K |
| 467 | NNVC | NanoViricides, Inc. | 28.07M | -2.99% | 105,577 | - |
| 468 | BCTX | BriaCell Therapeutics Corp. | 27.03M | -4.60% | 278,325 | - |
| 469 | CVM | CEL-SCI Corporation | 26.79M | -0.90% | 30,768 | - |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 26.47M | -0.41% | 14,689 | 14.99M |
| 471 | PLRZ | Polyrizon Ltd. | 26.37M | 1.02% | 60,498 | - |
| 472 | AEON | AEON Biopharma, Inc. | 26.32M | -4.59% | 70,980 | - |
| 473 | BRNS | Barinthus Biotherapeutics plc | 26.10M | 2.21% | 24,952 | 14.97M |
| 474 | LTRN | Lantern Pharma Inc. | 25.89M | -13.81% | 288,292 | - |
| 475 | TPST | Tempest Therapeutics, Inc. | 25.82M | -2.70% | 154,511 | - |
| 476 | JSPR | Jasper Therapeutics, Inc. | 25.34M | -7.56% | 212,122 | - |
| 477 | NRSN | NeuroSense Therapeutics Ltd. | 25.27M | 1.79% | 80,059 | - |
| 478 | CRIS | Curis, Inc. | 24.32M | -0.99% | 267,594 | 9.44M |
| 479 | MRKR | Marker Therapeutics, Inc. | 24.18M | -5.84% | 122,175 | 3.55M |
| 480 | SER | Serina Therapeutics, Inc. | 23.89M | -0.51% | 127,252 | 130.00K |
| 481 | LEXX | Lexaria Bioscience Corp. | 23.37M | -2.79% | 167,525 | 368.00K |
| 482 | XCUR | Exicure, Inc. | 23.20M | 0.05% | 85,936 | 500.00K |
| 483 | VTGN | Vistagen Therapeutics, Inc. | 22.64M | -5.13% | 684,093 | 789.00K |
| 484 | NCEL | NewcelX Ltd. | 22.38M | 34.15% | 352,304 | - |
| 485 | QNCX | Quince Therapeutics, Inc. | 22.17M | -0.73% | 2,138,014 | - |
| 486 | ALLR | Allarity Therapeutics, Inc. | 22.15M | - | 161,784 | 320.00K |
| 487 | VYNE | VYNE Therapeutics Inc. | 21.33M | -1.10% | 32,866 | 570.00K |
| 488 | CTXR | Citius Pharmaceuticals, Inc. | 20.88M | 8.50% | 3,254,706 | 3.94M |
| 489 | PBM | Psyence Biomedical Ltd. | 20.71M | 0.67% | 1,295,383 | - |
| 490 | OSRH | OSR Holdings, Inc. | 19.72M | 1.60% | 531,593 | 2.91M |
| 491 | COCP | Cocrystal Pharma, Inc. | 19.44M | -4.08% | 196,419 | - |
| 492 | PASG | Passage Bio, Inc. | 18.93M | -3.75% | 97,928 | - |
| 493 | QNTM | Quantum BioPharma Ltd. | 18.49M | -4.18% | 138,403 | - |
| 494 | TOVX | Theriva Biologics, Inc. | 17.49M | 2.12% | 11,638,676 | - |
| 495 | KTTA | Pasithea Therapeutics Corp. | 17.19M | -2.92% | 305,036 | - |
| 496 | LPCN | Lipocine Inc. | 17.15M | -2.89% | 113,455 | 1.98M |
| 497 | ICU | SeaStar Medical Holding Corporation | 16.93M | -4.93% | 53,295 | 1.23M |
| 498 | GNTA | Genenta Science S.p.A. | 16.56M | -1.69% | 46,164 | - |
| 499 | HIND | Vyome Holdings, Inc. | 15.86M | -0.44% | 12,831 | 319.71K |
| 500 | HOTH | Hoth Therapeutics, Inc. | 15.26M | -0.04% | 476,232 | - |